医学
纤维化
肝活检
肝纤维化
金标准(测试)
瞬态弹性成像
慢性肝病
弹性成像
生物标志物
活检
人口
肝病
内科学
胃肠病学
病理
放射科
肝硬化
超声波
环境卫生
化学
生物化学
作者
Michelle Lai,Nezam H. Afdhal
标识
DOI:10.1016/j.gtc.2019.02.002
摘要
All chronic liver disease can lead to liver fibrosis. Assessment of the severity of liver fibrosis is central to making treatment and management decisions. Liver biopsy, the gold standard for liver fibrosis assessment, is invasive and carries risks of complications and sampling errors. The use of noninvasive elastography-based radiologic methods of liver fibrosis determination is limited to centers that have the capabilities. Laboratory liver fibrosis determinations, both general clinical scoring systems and combination biomarker panels, are accessible to a wider population of clinicians for identifying patients at low risk of advanced fibrosis who do not need liver biopsies.
科研通智能强力驱动
Strongly Powered by AbleSci AI